Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04446442 · ClinicalTrials.gov registry record · NA

Cerebellar tDCS in Children With Autism Spectrum Disorder

A NA study of Autism Spectrum Disorder, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
2
Study locations

NCT04446442 is a NA study of Autism Spectrum Disorder that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 60 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (56% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04446442, a NA study of Autism Spectrum Disorder, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this research study is to investigate whether tDCS to the cerebellum (specifically, the right crus I/II area of the cerebellum) of children and young adults with autism spectrum disorders (ASD) is safe and to examine its effects on some of the symptoms of ASD, such as repetitive behaviors and hyperactivity.

Conditions Studied

Interventions

  • DEVICE tDCS

Study Locations (2)

Texas

  • Children's Medical Center - Dallas
  • University of Texas Southwestern - Dallas

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2019-06-04
Est. Completion 2026-03-31
Phase NA

What the Registry Record Tells You About NCT04446442

The ClinicalTrials.gov registry entry for NCT04446442 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (56% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which tDCS is the first listed.

NCT04446442 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04446442 about?

NCT04446442 is a clinical study titled "Cerebellar tDCS in Children With Autism Spectrum Disorder". The purpose of this research study is to investigate whether tDCS to the cerebellum (specifically, the right crus I/II area of the cerebellum) of children and young adults with autism spectrum disorders (ASD) is safe and to examine its effects on some of the symptoms of ASD, such as repetitive behav...

What is the current status of trial NCT04446442?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2019-06-04. Estimated completion is 2026-03-31.

What conditions does trial NCT04446442 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT04446442?

The interventions under investigation include: tDCS (DEVICE).

Who is sponsoring clinical trial NCT04446442?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04446442 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.